C3 and constipation disorder: Meanwhile, our study indicates that the difference in the therapeutic effectiveness of Urd and AELP in C3 KO and Lop-induced constipation models could be associated with the cAMP downstream signaling mechanism because this pathway involves the binding of Lop and the opioid receptors as well as C3a binds to its receptor [20,21].